Información del artÃculo
El Texto completo está disponible en PDF
Bibliografía
[1.]
J.A. Roth, A.S. Lichter, J.B. Putnam, A.A. Forastiere.
Cancer of the esophagus.
Cancer: principles and practice of oncology. 4th ed, pp. 776-817
[2.]
J. Borràs, J. Galcerán, L. Anglada, V. Moreno, J. Creus, F.X. Bosch, et al.
El cáncer en Tarragona 1980-1985 Estudio epidemiológico descriptivo. Registre de càncer Tarragona (RCT). Asociación Española contra el Cáncer.
Junta Provincial de Tarragona, 2 (1988), pp. 32-33
[3.]
M. Pera.
Epidemiology of esophageal cancer, especially adenocarcinoma of the esophagus and esophagogastric junction.
Recent Results Cancer Res, 155 (2000), pp. 1-14
[4.]
D. Sautereau.
Screening for early esophageal cancer: whom and how?.
Endoscopy, 31 (1999), pp. 325-328
[5.]
H. Worth Boyce.
Tumors of the esophagus.
Gastrointestinal disease: pathophysiology, diagnosis and management. 5th ed, pp. 401-408
[6.]
L.M. Brown, C.A. Swanson, G. Gridley, G.M. Swanson, D.T. Silverman, R.S. Greenberg, et al.
Dietary factors and the risk of squamous cell esophageal cancer among black and white men in the United States.
Cancer Causes Control, 9 (1998), pp. 467-474
[7.]
X. Leon, M. Quer, S. Díez, C. Orus, A. López-Pousa, J. Burges.
Second neoplasm in patients with head and neck cancer.
Head Neck, 21 (1999), pp. 204-210
[8.]
J. Isolauri, H. Makkula.
Lye ingestion and carcinoma of the esophagus.
Acta Chir Scand, 155 (1989), pp. 269-271
[9.]
J. Lagergren, R. Bergstrom, A. Lindgren, O. Nyren.
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.
N Engl J Med, 340 (1999), pp. 825-831
[10.]
J. Lagergren, R. Bergstrom, O. Nyren.
Association between body mass and adenocarcinoma of the esophagus and gastric cardia.
Ann Intern Med, 130 (1999), pp. 883-890
[11.]
G.C. O'Sullivan, D. Sheehan, A. Clarke, R. Stuart, J. Kelly, M.D. Kiely, et al.
Micrometastases in esophagogastric cancer: high detection rate in resected rib segments.
Gastroenterology, 116 (1999), pp. 543-548
[12.]
T.N. Walsh, N. Noonan, D. Hollywood, A. Kelly, N. Keeling, T.P.J. Hennessy.
A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.
N Engl J Med, 335 (1996), pp. 462-467
[13.]
J.F. Bosset, M. Gignoux, J.P. Triboulet, E. Tiret, G. Mantion, D. Elias, et al.
Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus.
N Engl J Med, 337 (1997), pp. 161-167
[14.]
A. Ruol.
and Panel of Experts. Multimodality treatment for nonmetastatic cancer of the thoracic esophagus. Results of a Consensus Conference.
Dis Esophagus, 9 (1995), pp. 501-508
[15.]
A.H. Hölscher, E. Bollschweiler, R. Bumm, H. Bartels, H. Hofler, J.R. Siewert.
Prognostic factors of resected adenocarcinoma of the esophagus.
Surgery, 118 (1995), pp. 845-855
[16.]
V. Vilgrain, D. Mompoint, L. Palazzo, Y. Menu, B. Gayet, P. Ollier, et al.
Staging of esophageal carcinoma: comparison of results with endoscopic sonography and C.T.
AJR Am J Roentgenol, 155 (1990), pp. 277-281
[17.]
P. Flamen, A. Lerut, E. Van Cutsem, W. De Wever, M. Peeters, S. Stroobants, et al.
Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.
J Clin Oncol, 18 (2000), pp. 3202-3210
[18.]
E. Vázquez-Sequeiros, I.D. Norton, J.E. Clain, K.K. Wang, A. Affi, M. Allen, et al.
Impact of EUS-guided-fine-needle aspiration on lymph node staging in patients with esophageal carcinoma.
Gastrointest Endosc, 53 (2001), pp. 751-757
[19.]
G. Zuccaro, T.W. Rice, J. Goldblum, S.V. Menderdorp, M. Becker, R. Pimentel, et al.
Endoscopic ultrasound cannot determine suitability for esophaguectomy after aggressive chemoradiotherapy for esophageal cancer.
Am J Gastroenterol, 94 (1999), pp. 906-912
[20.]
A. Chak, M.I. Canto, G.S. Cooper, G. Isenberg, J. Willis, N. Levitan, et al.
Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients.
Cancer, 88 (2000), pp. 1788-1795
[21.]
J.A. Ajani.
and Panel of Experts. NCCN Practice Guidelines for Upper Gastrointestinal Carcinomas.
NCCN Proceedings, 12 (1998), pp. 179-201
[22.]
N. Gawa, Y. Niwa, T. Arisawa, S. Hase, H. Goto, T. Hayakawa.
Preoperative staging of superficial esophageal carcinoma: comparison of an ultrasound probe and standard endoscopic ultrasonography.
Gastrointest Endosc, 44 (1996), pp. 388-393
[23.]
J.R. Siewert, U. Fink, A. Sendler, K. Becker, K. Bottcher, H.J. Feldmann, et al.
Gastric cancer.
Curr Probl Surg, 34 (1997), pp. 835-942
[24.]
B.L. Pratt, F.L. Greene.
Role of laparoscopy in the staging of malignant disease.
Surg Clin North Am, 80 (2000), pp. 1111-1126
[25.]
U. Fink, H.J. Stein, C. Schuhmacher, H.J. Wilke.
Neoadjuvant chemotherapy for gastric cancer: Update.
World J Surg, 19 (1995), pp. 509-516
[26.]
C.P. Schuhmacher, U. Fink, K. Becker, R. Busch, H.J. Dittler, J. Mueller, et al.
Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum. Closing results after 5 years of follow-up.
Cancer, 91 (2001), pp. 918-927
[27.]
C.C. Earle, J.A. Maronn.
Adjuvant chemotherapy after curative resection for gastric cancer: revisiting a meta-analysis of randomized trials.
Proc Am Soc Clin Oncol, 17 (1998), pp. 263
[28.]
C. Freeman, J.W. Berg, S.J. Cutler.
Occurrence and prognosis of extranodal lymphomas.
Cancer, 29 (1972), pp. 252-260
[29.]
P.G. Isaacson, D.H. Wright.
Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma.
Cancer, 52 (1983), pp. 1410-1416
[30.]
A.C. Wotherspoon, C. Doglioni, T.C. Diss, L. Pan, A. Moschini, M. De Boni, et al.
Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori.
Lancet, 342 (1993), pp. 575-577
[31.]
A.C. Wotherspoon, C. Ortiz-Hidalgo, M.R. Falzon, P.G. Isaacson.
Helicobacter pylori-associated gastritis and primary B-cell lymphoma.
Lancet, 338 (1991), pp. 1175-1176
[32.]
E. Roggero, E. Zucca, G. Pinotti, A. Pascarella, C. Capella, A. Sario, et al.
Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue.
Ann Intern Med, 122 (1995), pp. 767-769
[33.]
G. Cammarota, A. Tursi, M. Montalto, A. Papa, G. Branca, F.M. Vecchi, et al.
Prevention and treatment of low-grade B-cell primary gastric lymphoma by anti-Helicobacter pylori therapy.
J Clin Gastroenterol, 21 (1995), pp. 118-122
[34.]
E. Bayerdörffer, A. Neubauer, B. Rudolph, C. Thiede, N. Lehn, S. Eidt, et al.
Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection.
Lancet, 345 (1995), pp. 1591-1594
[35.]
A. Morgner, E. Bayerdörffer, A. Neubauer, C. Thiede, N. Lehn, E. Seifert, et al.
Remission of primary gastric low-grade MALT lymphoma after cure of Helicobacter pylori infection.
Gastroenterology, 112 (1997), pp. A618
[36.]
G.C. Caletti, A. Ferrari, E. Brocchi, L. Barbara.
Accuracy of endoscopic ultrasonography in the diagnosis and staging of gastric cancer and lymphoma.
Surgery, 113 (1993), pp. 14-27
[37.]
E. Bayerdörffer, A. Neubauer, B. Rudolph, C. Thied, N. Lehn, E. Eidt, et al.
Regression of lymphoma of mucosa-associated lyumphoid tissue type after cure of Helicobacter pylori infection.
Lancet, 345 (1995), pp. 1591-1594
[38.]
M. Sans, F. Feu, F. Bosch, E. Campo, A. Ginès, E. Montserrat, et al.
Regresión del linfoma gástrico tipo MALT de bajo grado después de la erradicación de Helicobacter pylori.
Gastroenterol Hepatol, 20 (1997), pp. 93
[39.]
A. Castells, J. Kroser, A.K. Rustgi.
Gastrointestinal neoplasms.
The Merck Manual of Geriatrics. 3rd ed, pp. 1134-1153
[40.]
A. Castells, J.M. Piqué.
Tumores intestinales.
Medicina Interna. 14.a ed, pp. 261-272
[41.]
J. Beynon, N.J. McMortensen, D.M.A. Foy, J.L. Channer, H. Rigby, J. Virjee.
Preoperative assessment of mesorectal lymph node involvement in rectal cancer.
Br J Surg, 76 (1989), pp. 276-279
[42.]
F. Glaser, P. Schlag, C. Herfarth.
Endorectal ultrasonography for the assessment of the invasion of rectal tumors and lymph node involvement.
Br J Surg, 77 (1990), pp. 883-887
[43.]
M.J. Wiersema, P. Vilmann, M. Giovannini, et al.
Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment.
Gastroenterology, 112 (1997), pp. 1087-1095
[44.]
R.G.H. Beets-Tan, G.L. Beets, R.F.A. Vliegen, A.G. Kessels, H. Van Boven, A. De Bruise, et al.
Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery.
Lancet, 357 (2001), pp. 497-504
[45.]
I.J. Adam, M.O. Mohamdee, I.G. Martin, N. Scott, P.J. Finan, D. Johnston, et al.
Role of circumferential involvement in the local recurrence of rectal cancer.
Lancet, 344 (1994), pp. 707-711
[46.]
R.J. Heald, R.D. Ryall.
Recurrence and survival after total mesorectal excision for rectal cancer.
Lancet, 1 (1986), pp. 1479-1482
[47.]
G.J. Frykholm, B. Grimelius, L. Pahlman.
Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secundary effects.
Dis Colon Rectum, 36 (1993), pp. 564-572
[48.]
A. Gerard, M. Buyse, B. Nordlinger, J. Loygne, F. Pene, P. Kempf, et al.
Preoperative radiotherapy as adjuvant treatment in rectal cancer: final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC).
Ann Surg, 208 (1988), pp. 606-614
[49.]
A. Horn, J.F. Halvorsen, O. Dhal.
Preoperative radiotherapy in operable rectal cancer.
Dis Colon Rectum, 33 (1990), pp. 823-828
[50.]
Swedish Rectal Cancer Trial.
Improved survival with preoperative radiotherapy in resectable rectal cancer.
N Engl J Med, 336 (1997), pp. 980-987
[51.]
Gastrointestinal Tumor Study Group.
Prolongation of the disease-free interval in surgically treated rectal carcinoma.
N Engl J Med, 312 (1985), pp. 1645-1672
[52.]
J.E. Krook, C.G. Moertel, L.L. Gunderson, H.S. Wieand, R.T. Collins, R.W. Beart, et al.
Effective surgical adjuvant therapy for high-risk rectal cancer.
N Engl J Med, 324 (1991), pp. 709-715
[53.]
Y. Francois, C.J. Nemoz, J. Baulieux, J. Vignal, J.P. Grandjean, C. Partensky, et al.
Influence of the interval between preoperative irradiation therapy and surgery on downstaging and the rate of sphincter-sparing for rectal cancer.
J Clin Oncol, 17 (1999), pp. 2396-2402
[54.]
T.A. Rich, J.M. Skipper, J.A. Ajani, J.M. Skipper, K.R. Cleary, D.M. Ota.
Preoperative infusional chemoradiation for stage T3 rectal cancer.
Int J Radiat Oncol Biol Phys, 32 (1995), pp. 1025-1029
[55.]
B.D. Minsky, A.M. Cohen, N. Kemeny, W.E. Enker, D.P. Kelsen, B. Reichman, et al.
Enhancement of radiation-induced downstaging of rectal cancer by 5-FU and high dose leucovorin chemotherapy.
J Clin Oncol, 10 (1992), pp. 79-84
[56.]
A. Castells, X. Bessa, M. Daniels, C. Ascaso, A.M. Lacy, J.C. García-Valdecasas, et al.
Value of postoperative surveillance after radical surgery for colorectal cancer. Results of a cohort study.
Dis Colon Rectum, 41 (1998), pp. 714-724
[57.]
X. Bessa, J. Saló, A. Arcusa, J.I. Elizalde, J. Boadas, E. Batiste-Alentorn, et al.
Effectiveness of postoperative surveillance after radical surgery for colorectal cancer. Preliminary results of a multicenter, randomized controlled trial [abstract].
Gastroenterology, 120 (2001), pp. A601
[58.]
D. Masascagni, L. Cobellini, P. Urciuoli, G. Di Matteo.
Endoluminal ultrasound for early detection of local recurrence of rectal cancer.
Br J Surg, 76 (1989), pp. 1176-1180
[59.]
J. Borrás, J. Galcerán, L.l. Anglada.
El càncer a Tarragona 1980-1985 Estudi epidemiològic descriptiu.
[60.]
J. Hoey.
Cancer of the pancreas: epidemiology and risk factors.
Gastroenterol Clin Biol, 9 (1985), pp. 765-766
[61.]
J.P. Cello.
Carcinoma of the pancreas.
Gastrointestinal disease: pathophysiology, diagnosis and management. 5th ed, pp. 1682-1684
[62.]
K.D. Lillemoe.
Current management of pancreatic carcinoma.
Ann Surg, 221 (1995), pp. 133-148
[63.]
M.F. Muller, C. Meyenberger, P. Bertschinger, R. Schaer, B. Marincek.
Pancreatic tumors: evaluation with endoscopic US, CT and MR imaging.
Radiology, 190 (1994), pp. 745-751
[64.]
A.L. Warshaw, C. Fernández-del-Castillo.
Pancreatic carcinoma.
N Engl J Med, 326 (1992), pp. 455-465
[65.]
T. Rösch, C. Braig, T. Gain, S. Fenerbach, J.R. Siewert, V. Schusdziarra, et al.
Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography.
Gastroenterology, 102 (1992), pp. 188-199
[66.]
K.Y. Chang, P. Nguyen, R.A. Erikson, T.E. Durbin, K.D. Katz.
The clinical utility of endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of pancreatic carcinoma.
Gastrointest Endosc, 45 (1997), pp. 387-393
[67.]
J. Suits, R. Frazee, R.S. Erikson.
Endoscopic ultrasound and fine needle aspiration for the evaluation of pancreatic masses.
Arch Surg, 134 (1999), pp. 639-643
[68.]
K. Chang, P. Nguyen, R.A. Erikson, T.E. Durbin, K.D. Katz.
The clinical utility of endoscopic ultrasound guided fine needle aspiration in the diagnosis and staging of pancreatic carcinoma.
Gastrointest Endosc, 45 (1997), pp. 387-393
[69.]
M.F. Brennan, T.J. Kinsella, E.S. Casper.
Cancer of the pancreas.
Cancer: principles and practice oncology. 4th ed, pp. 849-882
[70.]
C. Fondevila, J. Cubiella, M. Sans, L. Sabater, C. Ayuso, A. Castells, et al.
Utilidad de la ultrasonografía y la tomografía computarizada en la predicción de la resecabilidad del carcinoma de páncreas.
Med Clin (Barc), 111 (1998), pp. 604-647
[71.]
A. Soriano, M.C. Ayuso, J.R. Ayuso, M.T. De Caralt, R. Gilabert, M.A. Ginès, et al.
Preoperative staging and tumor resectability assessment in pancreatic cancer. Prospective study comparing endoscopic ultrasonography, compute tomography, magnetic resonance imaging and angiography.
Gastroenterology, 120 (2001), pp. A760
[72.]
J.H. Klinkenbijl, J. Jeekel, T. Sahmoud, R. Van Pel, M.L. Couvreur, C.H. Veenhof, et al.
Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region.
Ann Surg, 230 (1999), pp. 776-784
[73.]
J.P. Hoffman, S. Lipsitz, T. Pisansky, J.L. Weese, L. Solin, A.B. Beson.
Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas.
J Clin Oncol, 16 (1998), pp. 317-323
[74.]
Y. Nishimura, R. Hosotani, Y. Shibamoto, M. Korubo, S. Kanamori, K. Sasai, et al.
External and intraoperative radiotherapy for resectable and unresectable pancreatic cancer: analysis of survival rates and complications.
Int J Radiat Oncol Biol Phys, 39 (1997), pp. 39-49
[75.]
M.L. Rothenberg, M.J. Moore, M.C. Cripps, J.S. Andersen, R.K. Portenoy, H.A. Burris 3rd, et al.
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer.
Ann Oncol, 7 (1996), pp. 347-353
[76.]
C.L. Alter.
Palliative and supportive care of patients with pancreatic cancer.
Sem Oncol, 23 (1996), pp. 229-240
Copyright © 2002. Elsevier España, S.L.. Todos los derechos reservados
